PE Investors Plug $260M Into China's Innovent Biologics
Chinese biopharmaceutical company Innovent Biologics Inc. has raised $260 million from a group of investors led by private equity fund Future Industry Investment Fund, the companies said Wednesday, with plans to...To view the full article, register now.
Already a subscriber? Click here to view full article